🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 132 of 151

  1. UT-15C

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  2. UX003

    Ultragenyx UK Limited

    Mucopolysaccharidosis Type 7

    phase 2 small molecule completed

    1 trial

  3. UX007

    Ultragenyx UK Limited

    Glucose Transporter Type 1 Deficiency Syndrome

    phase 2 small molecule terminated

    1 trial

  4. UX007

    Ultragenyx UK Limited

    Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency

    phase 2 small molecule completed

    1 trial

  5. UX007

    Ultragenyx UK Limited

    Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

    phase 2 small molecule completed

    1 trial

  6. UX016

    Ultragenyx UK Limited

    GNE Myopathy

    phase 2 small molecule active

    1 trial

  7. UX053

    Ultragenyx UK Limited

    Glycogen Storage Disease Type III

    phase 2 mab terminated

    1 trial

  8. UX701

    Ultragenyx UK Limited

    Wilson Disease

    phase 2 gene therapy active

    1 trial

  9. Ubamatamab

    Regeneron UK Limited

    Recurrent Ovarian Cancer

    phase 2 small molecule active

    1 trial

  10. Ubamatamab

    Regeneron UK Limited

    SMARCB1-Deficient Malignancies

    phase 2 small molecule active

    1 trial

  11. Ubamatamab

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  12. Ubamatamab

    Regeneron UK Limited

    Advanced/Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  13. Ubamatamab, TOCILIZUMAB, Ubamatamab, Kevzara 175 mg/ml solution for injection, CEMIPLIMAB, LIBTAYO 350 mg concentrate for solution for infusion., Sarilumab

    Lacuna Pharma Pty Ltd

    Fallopian Tube Cancer, Endometrial Cancer, Ovarian Cancer, Primary Peritoneal Cancer

    phase 2 small molecule active

    1 trial

  14. Ublituximab

    TG THERAPEUTICS, INC.

    Relapsing Remitting Multiple Sclerosis

    phase 2 mab completed

    1 trial

  15. Ublituximab

    TG THERAPEUTICS, INC.

    Non-Hodgkins Lymphoma

    phase 2 small molecule completed

    2 trials

  16. Ublituximab

    TG THERAPEUTICS, INC.

    Follicular Lymphoma

    phase 2 small molecule terminated

    1 trial

  17. Ublituximab

    TG THERAPEUTICS, INC.

    Autoimmune Disorders

    phase 2 small molecule active

    1 trial

  18. Ublituximab

    TG THERAPEUTICS, INC.

    multiple sclerosis

    phase 2 small molecule active

    1 trial

  19. Udenafil

    Takeda

    Erectile Dysfunction

    phase 2 small molecule terminated

    2 trials

  20. Ultomiris 300 mg/30 mL concentrate for solution for infusion, Concentrate for solution for infusion

    Alexion Europe SAS

    Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN)

    phase 2 small molecule active

    1 trial

  21. Ultravist 370 mg/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    Patients with breast lesions undergoing further examination

    phase 2 small molecule active

    1 trial

  22. Ultravist 370 mg/ml soluzione iniettabile, OMNIPAQUE 350 mg I/ml soluzione iniettabile, VISIPAQUE 320 mg I/ml soluzione iniettabile

    Fondazione Telethon ETS

    breast pathology

    phase 2 small molecule active

    1 trial

  23. Umbilical Cord Blood Infusion

    Hospital Authority, Hong Kong

    Cerebral Palsy

    phase 2 mab terminated

    1 trial

  24. Umbilical Cord Mesenchymal Stem Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injuries

    phase 2 small molecule active

    2 trials

  25. Umbilical Cord Mesenchymal Stem Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial

  26. Umbralisib

    TG THERAPEUTICS, INC.

    Marginal Zone Lymphoma

    phase 2 small molecule completed

    1 trial

  27. Umbralisib

    TG THERAPEUTICS, INC.

    Chronic Lymphocytic Leukemia

    phase 2 small molecule completed

    4 trials

  28. Umbralisib

    TG THERAPEUTICS, INC.

    Lymphoma

    phase 2 small molecule terminated

    1 trial

  29. Upadacitinib

    AbbVie

    Non-Segmental Vitiligo

    phase 2 small molecule completed

    1 trial

  30. Upadacitinib

    AbbVie

    Hidradenitis Suppurativa (HS)

    phase 2 small molecule completed

    1 trial

  31. Upadacitinib, Upadacitinib

    AbbVie Deutschland GmbH & Co. KG

    Crohn's Disease (CD)

    phase 2 small molecule active

    1 trial

  32. Upamostat

    RedHill Biopharma

    SARS-CoV-2

    phase 2 small molecule completed

    1 trial

  33. Uplizna 100 mg concentrate for solution for infusion

    Amgen

    Immunoglobulin G4 related Disease (IgG4-RD)

    phase 2 small molecule active

    1 trial

  34. Uplizna 100 mg concentrate for solution for infusion

    Amgen

    Generalized Myasthenia Gravis

    phase 2 small molecule active

    1 trial

  35. Ursodeoxycholic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 small molecule completed

    1 trial

  36. Ursodeoxycholic acid

    Hospital Authority, Hong Kong

    Hepatitis D

    phase 2 small molecule active

    1 trial

  37. Use autologous cSVF + MSCs (cryo) for management of autoimmune component, anti-inflammatory and immune modulation

    Blackmores Limited

    Autism Spectrum Disorder

    phase 2 mab active

    1 trial

  38. Utidelone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 small molecule active

    1 trial

  39. VACl

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia, Adult

    phase 2 small molecule active

    1 trial

  40. VANCOMYCIN , MaaT013

    Lacuna Pharma Pty Ltd

    Gastrointestinal Acute Graft-versus-Host Disease (GI-aGvHD)

    phase 2 small molecule active

    1 trial

  41. VATS

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 other active

    1 trial

  42. VAXIGRIPTETRA, suspension injectable en seringue préremplie Vaccin grippal quadrivalent (inactivé, à virion fragmenté)

    Tour Hekla

    patients with stable coronary artery disease

    phase 2 small molecule active

    1 trial

  43. VAY736, ARTICAINE, COMBINATIONS, TENOFOVIR ALAFENAMIDE, PERFLUTREN, PHOSPHOLIPID MICROSPHERES, ENTECAVIR , -

    Novartis Pharmaceuticals

    Sjögren's syndrome

    phase 2 small molecule active

    1 trial

  44. VAY736, Placebo Solution for injection or infusion 0 mg/1 mL

    Novartis Pharmaceuticals

    Moderate to severe hidradenitis suppurativa

    phase 2 small molecule active

    1 trial

  45. VAY736, TENOFOVIR ALAFENAMIDE, ENTECAVIR , -, VAY736, VAY736, TENOFOVIR DISOPROXIL

    Novartis Pharmaceuticals

    Rheumatoid Arthritis, Sjögren’s Disease, Systemic Lupus erythematosus

    phase 2 small molecule active

    1 trial

  46. VB10.NEO

    Nektar Therapeutics UK Limited

    Locally Advanced or Metastatic Solid Tumours

    phase 2 mab completed

    1 trial

  47. VBR

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial

  48. VC-02 Combination Product

    Vertex Pharmaceuticals (Australia) Pty.

    Type 1 Diabetes Mellitus With Hypoglycemia

    phase 2 other completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.